Primary Site >> Liver Cancer

Gene >> KLRK1

  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.
PMID: 12569559
Ref: Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma.
PMID: 15383175
Ref: Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
PMID: 16024634
Ref: Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
PMID: 16168521
Ref: STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.
PMID: 17133483
Ref: Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.
PMID: 18025181
Ref: Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
PMID: 17764010
Ref: Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
PMID: 18519785
Ref: Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells.
PMID: 18685862
Ref: Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
PMID: 19109155
Ref: DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
PMID: 19404979
Ref: [Expression of NK cells receptor NKG2D from peripheral blood in patients with primary hepatic carcinoma and its clinical significance].
PMID: 19595184
Ref: Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
PMID: 19826051
Ref: Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.
PMID: 19998387
Ref: Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells.
PMID: 21106845
Ref: Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system.
PMID: 21873167
Ref: NKG2D and its ligands: key to immunotherapy of liver cancer?
PMID: 21798219
Ref: Interleukin-1beta enhances the production of soluble MICA in human hepatocellular carcinoma.
PMID: 22302133
Ref: Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.
PMID: 22396543
Ref: [Expression and significance of the NK cell receptors in primary hepatocellular carcinoma and paracancerous tissues].
PMID: 22558993
Ref: Interaction of Hepatitis C virus proteins with pattern recognition receptors.
PMID: 22726246
Ref: Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
PMID: 23225218
Ref: The combination therapy of alpha-galactosylceramide and 5-fluorouracil showed antitumor effect synergistically against liver tumor in mice.
PMID: 23420533
Ref: Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants.
PMID: 24010643
Ref: p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells.
PMID: 24043758
Ref: Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs.
PMID: 24061441
Ref: Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression.
PMID: 24107450
Ref: Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.
PMID: 23917076
Ref: Alloimmune activation promotes anti-cancer cytotoxicity after rat liver transplantation.
PMID: 24651497
Ref: hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
PMID: 24721706
Ref: Loss of expression of MHC class I-related chain A (MICA) is a frequent event and predicts poor survival in patients with hepatocellular carcinoma.
PMID: 25031731
Ref: MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
PMID: 25228093
Ref: Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
PMID: 25315249
Ref: MICA polymorphism: biology and importance in cancer.
PMID: 25330802
Ref: MICA SNPs and the NKG2D system in virus-induced HCC.
PMID: 25270965
Ref: Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.
PMID: 25393931
Ref: Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.
PMID: 25626490
Ref: Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells.
PMID: 25926643
Ref: Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor.
PMID: 26140244
Ref: Development of a screening method to identify regulators of MICA shedding.
PMID: 26299929
Ref: Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma.
PMID: 26574168
Ref: A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
PMID: 26791237
Ref: Failure recovery of circulating NKG2D(+)CD56(dim)NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence.
PMID: 26942056
Ref: Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway.
PMID: 27089390
Ref: Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
PMID: 27091211
Ref: Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition.
PMID: 27141341
Ref: Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
PMID: 27197065
Ref: Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.
PMID: 27262453
Ref: Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection.
PMID: 27630638
Ref: The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.
PMID: 28128200
Ref: Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-betaR II and NKG2D.
PMID: 28184969
Ref: Sunitinib Induces NK-kappaB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma Cells.
PMID: 28452850
Ref: Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-alpha via promoting the interaction of NKG2D and MICA.
PMID: 28585428
Ref: Oncolytic measles virus enhances antitumour responses of adoptive CD8(+)NKG2D(+) cells in hepatocellular carcinoma treatment.
PMID: 28701757
Ref: Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivo.
PMID: 28732877
Ref: MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients.
PMID: 28747084
Ref: Nano-Pulse Stimulation Ablates Orthotopic Rat Hepatocellular Carcinoma and Induces Innate and Adaptive Memory Immune Mechanisms that Prevent Recurrence.
PMID: 29533981
Ref: Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
PMID: 29568203
Ref: Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.
PMID: 29581297
Ref: Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.
PMID: 29713019
Ref: Ultrasound-guided radiofrequency ablation enhances natural killer-mediated antitumor immunity against liver cancer.
PMID: 29725428
Ref: CD8(+) T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma.
PMID: 29784005
Ref: IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction.
PMID: 29867983
Ref: The Paradoxical Role of NKG2D in Cancer Immunity.
PMID: 30150983
Ref: Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis.
PMID: 30238080
Ref: MicroRNA-34a Promotes MICB Expression in Hepatocytes.
PMID: 30256916